Video Highlights

CEO Jeff Kraws Discusses Antibiotic Resistance Projections and Impacts

CEO Jeff Kraws speaks with Arise XChange about Ebola Virus Treatments and Vaccines

Jeff Kraws on ABC News/Al Jazeera TV regarding J&J's $2.2B settlement

upcoming earnings reports
abakan advaxis aeterna zentaris amarin authentidate boston therapeutics genspera gentium livingston securities local lrad medgenics metastat neonode neuralstem opexa phmd pluristem “saleen unilife xoma